IL15 and myelodysplastic syndrome: We and others have previously shown that IL-15 stimulated CIK cells are a promising immunotherapeutic approach for the treatment of patients with impending relapse following allogeneic SCT for acute leukemia or myelodysplastic syndrome [13, 19, 22, 25, 26].